Clinical Trial Update: MHB018A Treatment in Patients With Chronic Thyroid Eye Disease [Phase 3]

View source ↗

Summary

This clinical trial update indicates that the Phase 3 study of MHB018A for chronic thyroid eye disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Eye Disease

Drugs mentioned

• MHB018A

Snippet

Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd | Conditions: Thyroid Eye Disease (TED) | Phase 3 | Status: RECRUITING